Should Chemotherapy Still Be Used to Treat All Muscle Invasive Bladder Cancer in the “Era of Immunotherapy”?

Expert Review of Anticancer Therapy - United Kingdom
doi 10.1080/14737140.2019.1625773
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

IL-9 BCG Immunotherapy for Non-Muscle Invasive Bladder Cancer in Europe

Japanese Journal of Urology
Urology
2007English

Should Aerosolized Antibiotics Be Used to Treat Ventilator-Associated Pneumonia?

Respiratory Care
MedicinePulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2016English

Neoadjuvant Chemotherapy Prior to Radical Cystectomy for Muscle-Invasive Bladder Cancer With Variant Histology

Cancer
Cancer ResearchOncology
2017English

Achieving the Achievable in Muscle-Invasive Bladder Cancer

Journal of the Canadian Urological Association
OncologyUrology
2012English

Efficient Delivery of Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Cancer
Cancer ResearchOncology
2011English

Amplification of 7p12 Is Associated With Pathologic Non-Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

American Journal of Pathology
Forensic MedicinePathology
2020English

Perioperative Chemotherapy for Muscle-Invasive Bladder Cancer: Closing the Gap Between Evidence and Practice

Canadian Urological Association Journal
Urology
2016English

Single Postoperative Instillation for Non-Muscle Invasive Bladder Cancer: Are There Still Any Indication?

Translational Andrology and Urology
Reproductive MedicineUrology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy